📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Advantages of multi-arm non-randomised sequentially allocated cohort designs for Phase II oncology trials. (2022)

First Author: Mossop H

Attributed to: Development of a 'humanised' model for renal cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41416-021-01613-5

PubMed Identifier: 34750494

Publication URI: http://europepmc.org/abstract/MED/34750494

Type: Journal Article/Review

Volume: 126

Parent Publication: British journal of cancer

Issue: 2

ISSN: 0007-0920